BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 1999
View Archived Issues
New data reported on thalidomide for several cancer indications
Read More
Preclinical data highlight Xcytrin's anticancer activity and novel mechanism of action
Read More
Vical updates product pipeline
Read More
StressGen to codevelop HspE7 with NCI for HPV diseases
Read More
OGS renegotiates license agreement with Searle for OGT-918
Read More
Ontogen completes phase I multidose oral study of MDR compound
Read More
InSite Vision licenses glaucoma diagnosis technology to Pharmacia & Upjohn
Read More
GelTex and Sankyo sign letter of intent for marketing CholestaGel and second-generation product
Read More
Preclinical data presented at AHA support promising profile of V-20
Read More
Vioxx now available in Canada for treatment of osteoarthritis
Read More
Optimal timing of cardiac imaging with 99mTc-NOET
Read More
Kinase inhibitors developed at Boehringer Ingelheim as potential anticancer agents
Read More
Another series of dopamine agonists for schizophrenia, Parkinson's disease from AHP
Read More
Pfizer's new MMP inhibitors selective for MMP-13 and/or TACE
Read More
New benzamides for CNS disorders, particularly epilepsy, presented by SB
Read More
Merck synthesizes novel oxytocin receptor antagonists with piperazine structure
Read More
Pharmaceutical agents useful as vitronectin antagonists and methods of use
Read More
Sumitomo's SM-13496: further clinical development may be handled overseas
Read More
Rheumatology update: two-year leflunomide data support sustained efficacy and safety
Read More
Ajinomoto expands European and U.S. development efforts
Read More
Sonus restructures EchoGen marketing agreement with Abbott
Read More
Lotronex recommended for approval by FDA advisory committee as IBS treatment
Read More
Hoe-140 effective against joint but not intestinal inflammation in rat model
Read More
Small patient study indicates potential new indication for leflunomide
Read More
Complement inhibitor 5G1.1 reduces signs and symptoms of RA in patient study
Read More
Foscan receives orphan drug designation in U.S.; MAA accepted in E.U.
Read More
Lorus files IND seeking clearance for phase I/II clinical trials of GTI-2040
Read More
Effects of IL-10 agonist IT-9302 on immunological markers in acute necrotizing pancreatitis
Read More
RPR/INGN-201 + radiotherapy provides supraadditive effects in prostate cancer xenograft models
Read More
